MR Imaging for the Evaluation of Diffuse Lung Disease: Where Are We?
Publication
, Journal Article
O'Sullivan-Murphy, B; Driehuys, B; Mammarappallil, J
Published in: Radiol Clin North Am
November 2022
Patients with diffuse lung diseases require thorough medical and social history and physical examinations, coupled with a multitude of laboratory tests, pulmonary function tests, and radiologic imaging to discern and manage the specific disease. This review summarizes the current state of imaging of various diffuse lung diseases by hyperpolarized MR imaging. The potential of hyperpolarized MR imaging as a clinical tool is outlined as a novel imaging approach that enables further understanding of the cause of diffuse lung diseases, permits earlier detection of disease progression before that found with pulmonary function tests, and can delineate physiologic response to lung therapies.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Radiol Clin North Am
DOI
EISSN
1557-8275
Publication Date
November 2022
Volume
60
Issue
6
Start / End Page
1021 / 1032
Location
United States
Related Subject Headings
- Xenon Isotopes
- Nuclear Medicine & Medical Imaging
- Magnetic Resonance Imaging
- Lung Diseases
- Lung
- Humans
- 3203 Dentistry
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
O’Sullivan-Murphy, B., Driehuys, B., & Mammarappallil, J. (2022). MR Imaging for the Evaluation of Diffuse Lung Disease: Where Are We? Radiol Clin North Am, 60(6), 1021–1032. https://doi.org/10.1016/j.rcl.2022.06.007
O’Sullivan-Murphy, Bryan, Bastiaan Driehuys, and Joseph Mammarappallil. “MR Imaging for the Evaluation of Diffuse Lung Disease: Where Are We?” Radiol Clin North Am 60, no. 6 (November 2022): 1021–32. https://doi.org/10.1016/j.rcl.2022.06.007.
O’Sullivan-Murphy B, Driehuys B, Mammarappallil J. MR Imaging for the Evaluation of Diffuse Lung Disease: Where Are We? Radiol Clin North Am. 2022 Nov;60(6):1021–32.
O’Sullivan-Murphy, Bryan, et al. “MR Imaging for the Evaluation of Diffuse Lung Disease: Where Are We?” Radiol Clin North Am, vol. 60, no. 6, Nov. 2022, pp. 1021–32. Pubmed, doi:10.1016/j.rcl.2022.06.007.
O’Sullivan-Murphy B, Driehuys B, Mammarappallil J. MR Imaging for the Evaluation of Diffuse Lung Disease: Where Are We? Radiol Clin North Am. 2022 Nov;60(6):1021–1032.
Published In
Radiol Clin North Am
DOI
EISSN
1557-8275
Publication Date
November 2022
Volume
60
Issue
6
Start / End Page
1021 / 1032
Location
United States
Related Subject Headings
- Xenon Isotopes
- Nuclear Medicine & Medical Imaging
- Magnetic Resonance Imaging
- Lung Diseases
- Lung
- Humans
- 3203 Dentistry
- 3202 Clinical sciences
- 1103 Clinical Sciences